Correlation Between Exelixis and Eledon Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Exelixis and Eledon Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Exelixis and Eledon Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Exelixis and Eledon Pharmaceuticals, you can compare the effects of market volatilities on Exelixis and Eledon Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Exelixis with a short position of Eledon Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Exelixis and Eledon Pharmaceuticals.

Diversification Opportunities for Exelixis and Eledon Pharmaceuticals

0.92

Correlation Coefficient

Exelixis  Eledon Pharmaceuticals

Almost no diversification

The 3 months correlation between Exelixis and Eledon is 0.92. Overlapping area represents the amount of risk that can be diversified away by holding Exelixis and Eledon Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eledon Pharmaceuticals and Exelixis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Exelixis are associated (or correlated) with Eledon Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eledon Pharmaceuticals has no effect on the direction of Exelixis i.e., Exelixis and Eledon Pharmaceuticals go up and down completely randomly.

Pair Corralation between Exelixis and Eledon Pharmaceuticals

Given the investment horizon of 90 days Exelixis is expected to generate 1.24 times less return on investment than Eledon Pharmaceuticals. But when comparing it to its historical volatility, Exelixis is 2.83 times less risky than Eledon Pharmaceuticals. It trades about 0.09 of its potential returns per unit of risk. Eledon Pharmaceuticals is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  285.00  in Eledon Pharmaceuticals on October 4, 2024 and sell it today you would earn a total of  127.00  from holding Eledon Pharmaceuticals or generate 44.56% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Strong
Accuracy	100.0%
Values	Daily Returns

Exelixis  vs.  Eledon Pharmaceuticals

Exelixis

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Exelixis are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite quite weak technical and fundamental indicators, Exelixis disclosed solid returns over the last few months and may actually be approaching a breakup point.

Eledon Pharmaceuticals

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Eledon Pharmaceuticals are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of very weak fundamental indicators, Eledon Pharmaceuticals displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Exelixis and Eledon Pharmaceuticals

The main advantage of trading using opposite Exelixis and Eledon Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Exelixis position performs unexpectedly, Eledon Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eledon Pharmaceuticals will offset losses from the drop in Eledon Pharmaceuticals' long position.

The idea behind Exelixis and Eledon Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.